By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Protalex, Inc. 



Albuquerque  New Mexico  87190  U.S.A.
Phone: 505-260-1726 Fax:


SEARCH JOBS


Industry
Biotechnology






Company News
Protalex (PRTX) Doses First Patient In Third Cohort Of European Phase Ib Study Of PRTX-100 In ITP 8/29/2017 8:03:14 AM
Protalex (PRTX) Awarded Grant From FDA Office Of Orphan Products Development To Foster Clinical Development Of PRTX-100 For The Treatment Of Immune Thrombocytopenia 8/17/2017 7:22:56 AM
Protalex (PRTX) Completes Data Analysis Of Second Dose Cohort Of U.S. Phase I/II Study Of PRTX-100 In ITP 8/1/2017 12:18:49 PM
Protalex (PRTX) Issues Letter To Shareholders 6/7/2017 7:49:22 AM
Protalex (PRTX) Significantly Strengthens Global Intellectual Property Portfolio For Proprietary Immunomodulatory Therapeutic 3/13/2017 6:37:42 AM
Protalex (PRTX) Provides Update On U.S. And EU Studies Of PRTX-100 To Treat Immune Thrombocytopenia 2/21/2017 8:33:48 AM
Protalex, Inc. (PRTX) Receives Positive Interim Review From Independent Safety Monitoring Committee In Its European Phase Ib Study Of PRTX-100 To Treat Immune Thrombocytopenia 5/2/2016 8:38:58 AM
Protalex, Inc. (PRTX) Announces Preliminary Findings From Phase I/II Continuation Trial Of PRTX-100 In Active Rheumatoid Arthritis Patients 4/25/2016 10:11:08 AM
Four Small-Cap Biotechs Investors Should Take a Look at 3/15/2016 6:53:30 AM
Protalex, Inc. (PRTX) Receives Positive Interim Review From Independent Safety Monitoring Committee In Its U.S. Phase I/II Study Of PRTX-100 For Immune Thrombocytopenia 2/29/2016 8:23:16 AM
12345678
//-->